Venom-derived peptide toxin
Margatoxin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Margatoxin →Peptide directory
Find a peptide
Public profiles inside a larger governed registry
Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.
The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.
Published profiles
Search profiles and sources
Antibody-peptide conjugate/combination biologic
Maridebart cafraglutide
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Maridebart cafraglutide →Research reference
Mastoparan
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Mastoparan →- Emerging
Mazdutide is a dual GLP-1 and glucagon receptor agonist investigated in metabolic disease. Weight-management and type 2 diabetes trials have different enrolled populations, regimens, comparators, and endpoints.
Evidence and record details
Evidence integrity map
Human 0Preclinical 0Durable IDs 3Open signals 1- Publication state
- Published profile
- Verified source records
- 28 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
IGF-1 splice-variant-derived research peptide
Mechano growth factor
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Mechano growth factor →Synthetic melanocortin analog
Melanotan I
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Melanotan I →- Emerging
Synthetic cyclic melanocortin-receptor agonist studied for pigmentation and other effects.
Evidence and record details
Evidence integrity map
Human 0Preclinical 1Durable IDs 7Open signals 1- Publication state
- Published profile
- Verified source records
- 25 source records verified
- Chemistry record
- Chemistry record on file
- Regulatory entries
- 2 published regulatory entries
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Melanocortin analog alias/reference
Melanotan-1
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Melanotan-1 →Bee-venom peptide
Melittin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Melittin →Endogenous opioid peptide
Met-enkephalin
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Met-enkephalin →Endogenous opioid peptide
Met-enkephalin-Arg-Gly-Leu
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Met-enkephalin-Arg-Gly-Leu →Endogenous opioid peptide
Met-enkephalin-Arg-Phe
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Met-enkephalin-Arg-Phe →Cyclic lipopeptide antifungal
Micafungin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Micafungin →Muramyl tripeptide-derived conjugate
Mifamurtide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Mifamurtide →Glucagon-derived peptide fragment
Mini-glucagon
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Mini-glucagon →Research reference
Montirelin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Montirelin →Endogenous gastrointestinal peptide hormone
Motilin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Motilin →Cyclic peptide CXCR4 antagonist
Motixafortide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Motixafortide →
How the public directory relates to the 500-record Master Registry
master registry transparency
500 master records, with governance status shown explicitly
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators
The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.
Explore the full Master Registry →What the profile status labels mean
Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.
Recently updated public records
When each public profile record was last changed — not clinical or scientific activity.